GVM±R in Patients With Relapsed or Refractory Aggressive NHL. | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
GVM±R in Patients With Relapsed or Refractory Aggressive NHL.	B-cell neoplasm, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, T-cell non-Hodgkin lymphoma, diffuse large B-cell lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, mature T-cell and NK-cell non-Hodgkin lymphoma, neoplasm	Recruiting	Phase 2	2025-05-14		NCT06244368

19 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Affiliated Cancer Hospital & Institute of Guangzhou Medical University	33
Beijing Tongren Hospital	60
Chengdu Shangjin Nanfu Hospital	2
China-Japan Friendship Hospital	135
First Affiliated Hospital of Harbin Medical University	64
First Hospital of China Medical University	92
Hebei Medical University Fourth Hospital	83
Institute of Hematology & Blood Diseases Hospital, China	285
Peking University Third Hospital	243
People's Hospital of Zhengzhou University	7
Shengjing Hospital	111
The Affiliated Ganzhou Hospital of Nanchang University	3
The First Affiliated Hospital of Bengbu Medical University	47
The First Affiliated Hospital of Dalian Medical University	36
The First Affiliated Hospital of Nanchang University	84
The First Hospital of Jilin University	154
The Second Affiliated Hospital of Harbin Medical University	36
The Second Affiliated Hospital of Kunming Medical University	33
Xuanwu Hospital, Beijing	232

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Institute of Hematology & Blood Diseases Hospital, CAMS & PUMC	Tianjin	China	1